A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Dragonfly Therapeutics
Centre Oscar Lambret
Dana-Farber Cancer Institute
Sun Yat-sen University
Dana-Farber Cancer Institute
Sun Yat-sen University
NeoImmuneTech
University of Michigan Rogel Cancer Center
Rutgers, The State University of New Jersey
Zhejiang Cancer Hospital
Institute of Oncology Ljubljana
ARCAGY/ GINECO GROUP
University of Alabama at Birmingham
University of Michigan Rogel Cancer Center
Cedars-Sinai Medical Center
University Hospital, Ghent
Impact Therapeutics, Inc.
SN BioScience
Cue Biopharma
Lumicell, Inc.
Abramson Cancer Center at Penn Medicine
AbbVie
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Shattuck Labs, Inc.
Risen (Suzhou) Pharma Tech Co., Ltd.
University Hospital, Tours
Hospices Civils de Lyon
Hospices Civils de Lyon
Memorial Sloan Kettering Cancer Center
I-Mab Biopharma US Limited
SpringWorks Therapeutics, Inc.
Seagen Inc.
Beth Israel Deaconess Medical Center
Sichuan Cancer Hospital and Research Institute
ARCAGY/ GINECO GROUP
Institut Curie
Hospices Civils de Lyon
Transgene
Mayo Clinic
University of Colorado, Denver
Wake Forest University Health Sciences
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Corcept Therapeutics
Merck Sharp & Dohme LLC
National Cancer Institute, Egypt
M.D. Anderson Cancer Center
Shanghai Escugen Biotechnology Co., Ltd